{"name":"Travere Therapeutics, Inc.","slug":"travere-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPdzZjSm56T3RwMHN3aUhWNktqY3dtZ3YtNDY1YzE3NnlWQ2hQRnQ4bG45bzJsWkhueG5sRmhFTENBQVZTckVkM1JZU3lTTVpnVXdnbGpWT1Qtck5iYTlKYzFtTnNFYXN5M2pxZmkydGZBM0hsMHp5SXZaaHFfZXBTY0FPemZBMVJqQzVqT1pmOHJEaFdNVjloSzQ5d0ljMjd1MnpQNg?oc=5","date":"2026-02-19","type":"pipeline","source":"TradingView","summary":"Travere Therapeutics, Inc. SEC 10-K Report - TradingView","headline":"Travere Therapeutics, Inc. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPaDVuZXVuZ0dFZXNaeHB3NUNwTG1WX1M5SVg5N3VEZkhKZDA4YmFOS2g5WVduX3ZRY05WaWcyb1pJV0hGV3pvNkJrbDR6eC1EdkR1eDI4dzlzWkNFTEdCVjdxVzZKcm9fSE4tYlFabmRYeE5oa1JxM2NEZjlGV1lQVDZBTTZzUmhXdmMxTzRuQW82SXFISUxmMEtnb3l5SzBVNFdzXw?oc=5","date":"2026-01-14","type":"regulatory","source":"Fierce Pharma","summary":"FDA delays decision on Travere's Filspari in key kidney disease indication - Fierce Pharma","headline":"FDA delays decision on Travere's Filspari in key kidney disease indication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOMG9Mb1hmb1ozcTNxcHp5VkZoY083VVAzbDFVRzRKVHVYcUp1b1dfRURjV09heXJzV3pqdGN3c1BfTjBJb29BZU9xYWxWU1A1MlR0NHJnendxZFFSVzdMSllxNEp1d3VfdWhXM2M4bHVwaHRXM2J6bUhud3dySF8taldCOXV5WmJoZkNKUmd5MGZUYnZqNzJXSGFoNmZvUkdsS2ZfZXdzWnZNN2dKRERsYUVRWHc0Z1lJWERSdWhxdGFqLWxoT3c?oc=5","date":"2026-01-13","type":"regulatory","source":"Reuters","summary":"Travere shares fall as US FDA extends review of rare kidney disease drug - Reuters","headline":"Travere shares fall as US FDA extends review of rare kidney disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNb3AzTzU3ZS1KSVkydmt3YjZSbVpfS3FfcU5UZ09sSURtZndIM01RVW84cUpmX2xwdU45bWhjZFB2bVNEdGZJVllQTjVTQTJ3NlEyUW85UmRkaHVMYktVQWgtUTE0QTZLT1NKeGZoX1ZwRFl4cHlwM215U2lJMVBLb29wNlpoOUdqdjJkd05yWGNpcVRjcjRfdDM3STFBN21Da2lXeTU0WQ?oc=5","date":"2026-01-13","type":"pipeline","source":"Investor's Business Daily","summary":"Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily","headline":"Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPbU5uS0ZhczloYmdnLXFhZFZpaGZCX0lFd3o2aThwZVpLZC1YNjJjb29yR3NfQ19udzdzZElXVFdfR3h5YmpEMC1vVFFBVU9PMmZkOEFYalFvUmhfR3JISGs1eGhFcFpmTDBpakdyVXFhcmVKcXhOOGd5dHQwa1RBd0ctdGRuclliOW9URjRoRmJ4bndrbzNyWUs1VG1GUklpN0hLZWJuRTBrWmd1ZmxjNlJralhyNjg?oc=5","date":"2025-11-26","type":"pipeline","source":"seekingalpha.com","summary":"Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA (TVTX) - seekingalpha.com","headline":"Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA (TVTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUk13ZGRMUlAyNTR6X3BwVjBZUVhwV25Eb1NxaGdIcWZXRHM3MEJsS1hWYTFVUlE1c19NZEhCVFZ3cU9jMXNhZzkyWTRiTlFjWXNsRnhFRDc1bDRQYUpELUpuVkFvODNBTTJWYnBnbDlnWWQ5ek94cDhZbEhFQWt2bjBSbUFRTDgzUmYxcFl4NkN6dkloZ3YzLXpkcnNmRnAzQkxOZWhTc2k?oc=5","date":"2025-10-31","type":"earnings","source":"BioSpace","summary":"Travere Therapeutics Reports Third Quarter 2025 Financial Results - BioSpace","headline":"Travere Therapeutics Reports Third Quarter 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-29","type":"pipeline","source":"simplywall.st","summary":"Would Travere Therapeutics (NASDAQ:TVTX) Be Better Off With Less Debt? - simplywall.st","headline":"Would Travere Therapeutics (NASDAQ:TVTX) Be Better Off With Less Debt?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxONndadnpLc3JuclR2czF4aUVSQTFPNjZxOFd4cVR1NFVVb2I2OGZJS09Odl9lNXllemNTU3Q2TW5Mck5iSzh2ZHYzcEhpNk0tLVViRUFja0pROWo1cEs0QXo0MlJNbnBXY0F3Z216cFl0WURLaWZhYVlycmFkRnl5cmZxWUFZSEk3Rk9DYV9IUDZGODNMTHYtc2dKVlJOT3oyanFUQ2g4VS1XOXdZN2U0cTVMZGo3TE85UGVNZVVBZ2YwT0N2UGZncGJRU19yUm9pY1BiSURFUmY2bVpMVHRJZnM1LWhwYjA?oc=5","date":"2025-04-29","type":"regulatory","source":"prnewswire.com","summary":"CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy - prnewswire.com","headline":"CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5TZl9TcFBxNEVrZjM4ZW9HN1Jtc3pDeF9WZ1ZiS1hnSGRDWUg4SnlkdmFLenA2NkRVTVFMS0tRR29CV2lyUXNPcU51OXg0MXRPZk9v?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"TVTX Stock Price, News & Analysis - Stock Titan","headline":"TVTX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPZ0dzVEd5YzFxZmxFZnQ3WEQxZVR0TTFRX3VmaXVjcGNTTFJ3ZFNUVGNkSER0anFnaHFNNE1FSHp5WV8ta3ZvblBnTm9EYnNOVlptdkNqbUU4ajMzRkowU1dJZVllY0djckNBOXhYMGlMUVhwVXdpTUhTMWJsS2docy1WaXlUWnk5M0xaMDJwQzBXU0F4ZTJYcGl1QXFfWjBpNjc5SXNMakdkSktka0tPR1V0Y0M?oc=5","date":"2025-02-12","type":"regulatory","source":"Pharmaceutical Technology","summary":"Travere takes rare disease kidney drug to FDA despite failed trial - Pharmaceutical Technology","headline":"Travere takes rare disease kidney drug to FDA despite failed trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE50ZkoxOUVId0c3RW1fU092RVZGSUp1M1h4amZkVVlBT3BMOEp5bExPSDdrS3VBUnJiM254VnhtdGtabHJpcFNiYUdsdWhhaE5iQ2c?oc=5","date":"2021-01-30","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Travere Therapeutics, Inc. (TVTX) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Travere Therapeutics, Inc. (TVTX) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNOWdCYVM4Y3A2aC1LcHNuX3BQYnFYandxbm92bF9vUkdJWVF3MTVNU08waU1DT0VkZjFka1BjOFV0LVZLOUd6LUJPMjJWOHdQeE5PNTRxd0gwYWstblNkUGRkdkNfcTYzUmJ0ZzBVcGdCcXhhclBJckNNZmVzbmtfdnhLM3VOWTh3d2pUX09HWU4wOVEzX1JPQmpob0Y0V2FPeHFlOA?oc=5","date":"2020-11-17","type":"pipeline","source":"Fierce Biotech","summary":"Retrophin sheds Shkreli connection with new name: Travere Therapeutics - Fierce Biotech","headline":"Retrophin sheds Shkreli connection with new name: Travere Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}